Pharmaceutical products for the prevention and treatment of immunological diseases, pharmaceutical preparations for use in the treatment of central nervous system [CNS] diseases, pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis and Alzheimer's
ADVERTISED
on 06 Nov 2024
ZUNRYPKI
GENZYME CORPORATION
2288912 · 25 Oct 2023
005
Class 005
Pharmaceutical Products
Pharmaceutical products for the prevention and treatment of immunological diseases, pharmaceutical preparations for use in the treatment of central nervous system [CNS] diseases, pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis and Alzheimer's
Pharmaceutical products for the prevention and treatment of immunologi...
